Cargando…

Predicting Cardiovascular Outcomes by Baseline Lipoprotein(a) Concentrations: A Large Cohort and Long‐Term Follow‐up Study on Real‐World Patients Receiving Percutaneous Coronary Intervention

BACKGROUND: Although several studies have indicated that lipoprotein(a) is a useful prognostic predictor for patients following percutaneous coronary intervention (PCI), previous observations have somewhat been limited by either small sample size or short‐term follow‐up. Hence, this study aimed to e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hui‐Hui, Cao, Ye‐Xuan, Jin, Jing‐Lu, Zhang, Hui‐Wen, Hua, Qi, Li, Yan‐Fang, Guo, Yuan‐Lin, Zhu, Cheng‐Gang, Wu, Na‐Qiong, Xu, Rui‐Xia, Chen, Xie‐Hui, Li, Jian‐Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033882/ https://www.ncbi.nlm.nih.gov/pubmed/32013705 http://dx.doi.org/10.1161/JAHA.119.014581

Ejemplares similares

Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Different Metabolic Phenotypes
por: Jin, Jing-Lu, et al.
Publicado: (2022)

Long-term prognostic utility of low-density lipoprotein (LDL) triglyceride in real-world patients with coronary artery disease and diabetes or prediabetes
por: Jin, Jing-Lu, et al.
Publicado: (2020)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
por: Chen, Zhihao, et al.
Publicado: (2018)

In-hospital and one-year outcomes in cancer patients receiving percutaneous coronary intervention for acute myocardial infarction: A real-world study
por: Tang, Manyun, et al.
Publicado: (2023)

Liver Fibrosis Scoring Systems as Novel Tools for Predicting Cardiovascular Outcomes in Patients Following Elective Percutaneous Coronary Intervention
por: Liu, Hui‐Hui, et al.
Publicado: (2021)

The impact of successful chronic total occlusion percutaneous coronary intervention on long-term clinical outcomes in real world
por: Gong, Xuhe, et al.
Publicado: (2021)

Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study
por: Jin, Jing-Lu, et al.
Publicado: (2020)

Effect of Ticagrelor on Coronary Blood Flow and Prognosis in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in Real World
por: Jin, Yan-Yan, et al.
Publicado: (2018)

Serum concentrations of small dense low‐density lipoprotein cholesterol and lipoprotein(a) are related to coronary arteriostenosis in Takayasu arteritis
por: Chen, Si, et al.
Publicado: (2021)

Association of trajectories of non-high-density lipoprotein cholesterol concentration with risk of cardiovascular disease: the Kailuan Study
por: Ding, Xiong, et al.
Publicado: (2023)

Relationship of High‐Density Lipoprotein Cholesterol With Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention in Patients With Low‐Density Lipoprotein Cholesterol Below 70 mg/dL
por: Li, Xiao‐Lin, et al.
Publicado: (2015)

Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein(a), and inflammation, on prognosis of statin-treated patients with chronic coronary syndrome
por: Liu, Hui-Hui, et al.
Publicado: (2022)

Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention
por: Zhao, Zi-wen, et al.
Publicado: (2019)

Prognostic utility of lipoprotein(a) combined with fibrinogen in patients with stable coronary artery disease: a prospective, large cohort study
por: Zhang, Yan, et al.
Publicado: (2020)

Impact of diabetes and hypertension on cardiovascular outcomes in patients with coronary artery disease receiving percutaneous coronary intervention
por: Lin, Mao-Jen, et al.
Publicado: (2017)

Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
por: Zhang, Shuang, et al.
Publicado: (2022)

Lipoprotein (a) predicts recurrent worse outcomes in type 2 diabetes mellitus patients with prior cardiovascular events: a prospective, observational cohort study
por: Zhang, Yan, et al.
Publicado: (2020)

Atherogenic dyslipidaemia and cardiovascular events in patients with diabetes or pre-diabetes and stable coronary artery disease: a prospective, cohort study
por: Jin, Jing-Lu, et al.
Publicado: (2021)

The Prognostic Value of Cardiac Troponin I in Patients with or without Three-Vessel Disease Undergoing Complete Percutaneous Coronary Intervention
por: Li, Zhi-Fan, et al.
Publicado: (2022)

Moderately elevated lipoprotein (a) levels are associated with an earlier need for percutaneous coronary intervention in recurrent cardiovascular disease
por: Hoursalas, Athanasios, et al.
Publicado: (2022)

Correlation between monocyte to high-density lipoprotein ratio and major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention
por: Yu, Rong, et al.
Publicado: (2021)

Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort study
por: Peng, Jia, et al.
Publicado: (2021)

Relationship between small dense low density lipoprotein and cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Zhang, Jianwei, et al.
Publicado: (2021)

Percutaneous coronary intervention with anomalous origin of right coronary artery: case reports and literature review
por: Hong, Li-Feng, et al.
Publicado: (2013)

Impact of Non-Alcoholic Fatty Liver Disease on Cardiovascular Outcomes in Patients With Stable Coronary Artery Disease: A Matched Case–Control Study
por: Liu, Hui-Hui, et al.
Publicado: (2019)

Lack of association between lipoprotein(a) genetic variants and subsequent cardiovascular events in Chinese Han patients with coronary artery disease after percutaneous coronary intervention
por: Li, Zhi-Gen, et al.
Publicado: (2013)

High-density lipoprotein cholesterol concentration and acute kidney injury after noncardiac surgery
por: Zhou, Yan, et al.
Publicado: (2020)

Association of statin use and increase in lipoprotein(a): a real-world database research
por: Feng, Tienan, et al.
Publicado: (2023)

Free fatty acids and cardiovascular outcome: a Chinese cohort study on stable coronary artery disease
por: Zhang, Hui-Wen, et al.
Publicado: (2017)

Heart-type fatty acid binding protein predicts cardiovascular events in patients with stable coronary artery disease: a prospective cohort study
por: Zhang, Hui-Wen, et al.
Publicado: (2020)

Elevated Baseline Serum Fibrinogen: Effect on 2‐Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention
por: Ang, Lawrence, et al.
Publicado: (2017)

Impact of percutaneous coronary intervention on patients with impaired baseline renal function
por: Yadav, Deepti, et al.
Publicado: (2020)

Real-world outcomes in treatment of highly calcified coronary lesions with intravascular shockwave lithotripsy
por: Wiens, Evan J., et al.
Publicado: (2021)

Acute Migraine Prescription Patterns Vary by Baseline Cardiovascular Risk and Clinical Characteristics: A Real-World Evidence Study
por: Li, Hu, et al.
Publicado: (2020)

A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention
por: Kong, Shuting, et al.
Publicado: (2021)

Genetic Risk Scores Associated with Baseline Lipoprotein Subfraction Concentrations Do Not Associate with Their Responses to Fenofibrate
por: Frazier-Wood, Alexis C., et al.
Publicado: (2014)

Relation between high density lipoprotein particles concentration and cardiovascular events: a meta-analysis
por: Wu, YuJing, et al.
Publicado: (2018)

Prognostic implication of stress hyperglycemia in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Wang, Man, et al.
Publicado: (2023)

Cost-effectiveness of follow-up invasive coronary angiography after percutaneous coronary stenting: a real-world observational cohort study in Japan
por: Shiina, Tetsuya, et al.
Publicado: (2022)

Adherence with cardiovascular medications and the outcomes in patients with coronary arterial disease: “Real‐world” evidence
por: Chen, Chen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dn35ip5dus3096d94e855jveja